Revvity
€10,000 invested in 2016 · with dividend reinvestment
Dividend history
About Revvity
Revvity is a life sciences and diagnostics company, formed from the former PerkinElmer after it sold its legacy analytical instruments business, and now focused on reagents, software and diagnostics for research and clinical labs. The reshaped portfolio aims at higher-margin, faster-growing areas such as genomics, newborn screening and drug discovery tools. Revvity carries a long formal dividend history inherited from PerkinElmer, but the payout is tiny and the yield close to negligible, reflecting a deliberate policy of returning very little cash while reinvesting in growth and acquisitions. Its middling score captures that mismatch: a token dividend attached to a company that behaves far more like a growth-oriented life sciences business than an income stock.